- Home
- KOD vs NIM Comparison
KOD vs NIM Comparison
Compare KOD & NIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- NIM
- Stock Information
- Founded
- KOD 2009
- NIM 1992
- Country
- KOD United States
- NIM United States
- Employees
- KOD N/A
- NIM N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- NIM Trusts Except Educational Religious and Charitable
- Sector
- KOD Health Care
- NIM Finance
- Exchange
- KOD Nasdaq
- NIM Nasdaq
- Market Cap
- KOD 198.4M
- NIM 115.4M
- IPO Year
- KOD 2018
- NIM N/A
- Fundamental
- Price
- KOD $9.84
- NIM $9.30
- Analyst Decision
- KOD Hold
- NIM
- Analyst Count
- KOD 4
- NIM 0
- Target Price
- KOD $11.75
- NIM N/A
- AVG Volume (30 Days)
- KOD 443.4K
- NIM 35.4K
- Earning Date
- KOD 11-13-2025
- NIM 01-01-0001
- Dividend Yield
- KOD N/A
- NIM 3.46%
- EPS Growth
- KOD N/A
- NIM N/A
- EPS
- KOD N/A
- NIM N/A
- Revenue
- KOD N/A
- NIM N/A
- Revenue This Year
- KOD N/A
- NIM N/A
- Revenue Next Year
- KOD N/A
- NIM N/A
- P/E Ratio
- KOD N/A
- NIM N/A
- Revenue Growth
- KOD N/A
- NIM N/A
- 52 Week Low
- KOD $1.92
- NIM $8.28
- 52 Week High
- KOD $11.60
- NIM $9.74
- Technical
- Relative Strength Index (RSI)
- KOD 56.74
- NIM 63.20
- Support Level
- KOD $9.10
- NIM $9.21
- Resistance Level
- KOD $9.93
- NIM $9.34
- Average True Range (ATR)
- KOD 0.74
- NIM 0.07
- MACD
- KOD -0.11
- NIM 0.01
- Stochastic Oscillator
- KOD 66.52
- NIM 75.93
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.